Edition:
United Kingdom

Unichem Laboratories Ltd (UNLB.NS)

UNLB.NS on National Stock Exchange of India

178.00INR
19 Jun 2019
Change (% chg)

-- (--)
Prev Close
Rs178.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
82,171
52-wk High
Rs259.50
52-wk Low
Rs170.90

Latest Key Developments (Source: Significant Developments)

Unichem Laboratories March-qtr Profit Surges
Friday, 24 May 2019 

May 24 (Reuters) - Unichem Laboratories Ltd ::RECOMMENDED DIVIDEND OF 4 RUPEES PER SHARE.MARCH QUARTER PROFIT 99.4 MILLION RUPEES VERSUS PROFIT 22.5 MILLION RUPEES YEAR AGO.MARCH QUARTER REVENUE FROM OPERATIONS 2.77 BILLION RUPEES VERSUS 2.03 BILLION RUPEES YEAR AGO.  Full Article

Unichem Laboratories Gets Final Approval For Tadalafil Tablets From U.S FDA
Wednesday, 27 Mar 2019 

March 27 (Reuters) - Unichem Laboratories Ltd ::GETS FINAL APPROVAL FOR ITS ANDA, TADALAFIL TABLETS, 2.5 MG, 5 MG 10 MG AND 20 MG FROM U.S FDA.  Full Article

Unichem Laboratories Gets EIR For Post Marketing Adverse Drug Experience Inspection
Monday, 26 Nov 2018 

Nov 26 (Reuters) - Unichem Laboratories Ltd ::UNICHEM LABORATORIES GETS EIR FOR POST MARKETING ADVERSE DRUG EXPERIENCE INSPECTION CONDUCTED BY USFDA FROM JUNE 25 TO JUNE 29.  Full Article

India's Unichem Labs Sept Qtr Profit Falls
Tuesday, 30 Oct 2018 

Oct 30 (Reuters) - Unichem Laboratories Ltd ::SEPT QUARTER PROFIT 152.1 MILLION RUPEES VERSUS PROFIT 458.2 MILLION RUPEES YEAR AGO.SEPT QUARTER REVENUE FROM OPERATIONS 2.46 BILLION RUPEES VERSUS 1.63 BILLION RUPEES YEAR AGO.  Full Article

Unichem Laboratories Gets ANDA Approval From U.S. FDA For Valsartan Tablets, USP
Monday, 7 May 2018 

May 7 (Reuters) - Unichem Laboratories Ltd ::SAYS GOT ANDA APPROVAL FROM USFDA FOR VALSARTAN TABLETS, USP.SAYS PRODUCT WILL BE COMMERCIALIZED FROM UNICHEM'S GHAZIABAD PLANT .  Full Article

Unichem Laboratories Seeks Shareholders' Nod For Share Buyback Proposal
Wednesday, 10 Jan 2018 

Jan 10 (Reuters) - Unichem Laboratories Ltd ::SEEKS SHAREHOLDERS' NOD FOR SHARE BUYBACK PROPOSAL WORTH 8.86 BILLION RUPEES.  Full Article

Unichem Labs Dec-qtr Profit Rises
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Unichem Laboratories Ltd ::SAYS APPROVED BUYBACK OF EQUITY SHARES.DEC QUARTER PROFIT 25.07 BILLION RUPEES VERSUS 261.1 MILLION RUPEES YEAR AGO.DEC QUARTER REVENUE FROM OPERATIONS 1.59 BILLION RUPEES VERSUS 1.56 BILLION RUPEES YEAR AGO.DEC QUARTER GAIN ON SALE OF IDENTIFIED BUSINESS (NET)32.17 BILLION RUPEES.SAYS BUYBACK WORTH ABOUT 8.86 BILLION RUPEES.  Full Article

Unichem Laboratories To Consider Proposal To Buy-Back Shares Of Co
Wednesday, 3 Jan 2018 

Jan 3 (Reuters) - Unichem Laboratories Ltd ::SAYS TO CONSIDER PROPOSAL TO BUY-BACK SHARES OF CO.  Full Article

India's Unichem Laboratories Sept-qtr profit rises
Friday, 3 Nov 2017 

Nov 3 (Reuters) - Unichem Laboratories Ltd ::Sept quarter profit 458.2 million rupees versus profit of 205.2 million rupees year ago.Sept quarter revenue from operations 4.28 billion rupees versus 3.68 billion rupees year ago.  Full Article

Unichem Labs gets ANDA approval for Irbesartan and hydrochlorothiazide tablets
Wednesday, 20 Sep 2017 

Sept 20 (Reuters) - Unichem Laboratories Ltd :Says gets ANDA approval from USFDA for irbesartan and hydrochlorothiazide tablets usp.  Full Article